Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

CONDITION

Metabolic and Endocrine

GENDER

Both males and females

AGE GROUP

18 years and above

TRIAL STATUS

Recruiting

A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

CONTACT DETAILS

Phone Number: 1300742326
Email: info@paratusclinical.com
Location: Suite A8, Kanwal Medical Complex, 654 Pacific Highway, KANWAL NSW 2259

CONTACT SITE

Approved By: Bellberry Ltd              

Clinical Trial Registry Link: Click Here